End of Year Message from Lupus Research Alliance President & CEO Albert T. Roy Story December 10, 2025 2025 has been an extraordinary year of momentum at the Lupus Research Alliance and clinical affiliate Lupus Therapeutics. Hear...
Lupus Research Alliance Showcases Research that will Shape Next Generation Treatments at ACR Convergence 2025 Press Release October 21, 2025 4 original posters to be presented on cell therapy, patient-reported outcomes, innovative recruitment strategies, and clinical trial retention...
Community Spotlight: How Peer Educator Martha Chisholm is Living – And Advocating For – Life Beyond Lupus Story August 22, 2025 Martha Chisholm spent years seeking answers. Now, as a patient advocate, she’s helping others find theirs. What was once...
Clinical Affiliate Lupus Therapeutics Names Grantee for Groundbreaking IDEAL Initiative News Update July 24, 2025 Could the future of lupus care be on your plate? Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance,...
Lupus Research Alliance and Clinical Affiliate Lupus Therapeutics Selected as Inaugural Strategic Collaborators with Vie Ventures to Advance Innovative Autoimmune Therapies News Update July 9, 2025 The Lupus Research Alliance and clinical affiliate Lupus Therapeutics are proud to be selected as inaugural collaborators of the...
How Are the New Lupus Nephritis Guidelines Impacting Treatment? News Update March 1, 2025 Perspective by renowned nephrologist Dr. Brad Rovin Recognized as National Kidney Month, March is the ideal time to learn more...
LRA Forum for Discovery Showcases Cutting-Edge Lupus Research News Update December 11, 2024 The Lupus Research Alliance (LRA) hosted its highly anticipated annual scientific conference, Forum for Discovery (FFD), November 11-13 in...
Celebrating Native American Heritage Month: Meet Dr. Kent Kwoh, A Champion for Health Equity Story November 14, 2024 During Native American Heritage Month, we celebrate a dedicated champion of health equity. As Chief of Rheumatology and Director...
Investigational Treatment Dapirolizumab Pegol Shows Positive Results in Phase 3 Clinical Trial Press Release September 24, 2024 Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share positive topline results from...
Inspired by Patient Need, Dermatologist Specializes in Cutaneous Lupus Story July 11, 2024 Dr. Victoria Werth decided to focus her career on researching and treating cutaneous (skin) lupus erythematosus because she saw...
Meet Unstoppable Advocate for Minority Health Christopher Reed Story April 2, 2024 Determined to alleviate healthcare disparities for minorities, J. Christopher Reed, JD, urges our lupus community to use the power...
Lupus Peer-to-Peer Early Education Program Expands News Update March 28, 2024 Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, has announced an innovative expansion of the highly...